30 research outputs found
Pairing of Homologous Regions in the Mouse Genome Is Associated with Transcription but Not Imprinting Status
This work was funded by the BBSRC, grant BB/H088071/1 (www.bbsrc.ac.uk), MRC, grant G0700760 (www.mrc.ac.uk), Wellcome Trust, grant 095645/Z/11/Z (www.wellcome.ac.uk) and the EU through EpiGeneSys (www.epigenesys.eu) and Blueprint (www.blueprint-epigenome.eu). C.K. was funded by the DFG, personal fellowship KR 3317/2-1 (www.dfg.de) and CTR, personal short term fellowship (www.trophoblast.cam.ac.uk). M.J.H. received funding through grant NCI/NIH 2RO1 CA089426 (www.nih.gov)
The importance of imprinting in the human placenta.
As a field of study, genomic imprinting has grown rapidly in the last 20 years, with a growing figure of around 100 imprinted genes known in the mouse and approximately 50 in the human. The imprinted expression of genes may be transient and highly tissue-specific, and there are potentially hundreds of other, as yet undiscovered, imprinted transcripts. The placenta is notable amongst mammalian organs for its high and prolific expression of imprinted genes. This review discusses the development of the human placenta and focuses on the function of imprinting in this organ. Imprinting is potentially a mechanism to balance parental resource allocation and it plays an important role in growth. The placenta, as the interface between mother and fetus, is central to prenatal growth control. The expression of genes subject to parental allelic expression bias has, over the years, been shown to be essential for the normal development and physiology of the placenta. In this review we also discuss the significance of genes that lack conservation of imprinting between mice and humans, genes whose imprinted expression is often placental-specific. Finally, we illustrate the importance of imprinting in the postnatal human in terms of several human imprinting disorders, with consideration of the brain as a key organ for imprinted gene expression after birth
From Structure Prediction to Genomic Screens for Novel Non-Coding RNAs
Non-coding RNAs (ncRNAs) are receiving more and more attention not only as an abundant class of genes, but also as regulatory structural elements (some located in mRNAs). A key feature of RNA function is its structure. Computational methods were developed early for folding and prediction of RNA structure with the aim of assisting in functional analysis. With the discovery of more and more ncRNAs, it has become clear that a large fraction of these are highly structured. Interestingly, a large part of the structure is comprised of regular Watson-Crick and GU wobble base pairs. This and the increased amount of available genomes have made it possible to employ structure-based methods for genomic screens. The field has moved from folding prediction of single sequences to computational screens for ncRNAs in genomic sequence using the RNA structure as the main characteristic feature. Whereas early methods focused on energy-directed folding of single sequences, comparative analysis based on structure preserving changes of base pairs has been efficient in improving accuracy, and today this constitutes a key component in genomic screens. Here, we cover the basic principles of RNA folding and touch upon some of the concepts in current methods that have been applied in genomic screens for de novo RNA structures in searches for novel ncRNA genes and regulatory RNA structure on mRNAs. We discuss the strengths and weaknesses of the different strategies and how they can complement each other
The Genetic Signatures of Noncoding RNAs
The majority of the genome in animals and plants is transcribed in a developmentally regulated manner to produce large numbers of nonβprotein-coding RNAs (ncRNAs), whose incidence increases with developmental complexity. There is growing evidence that these transcripts are functional, particularly in the regulation of epigenetic processes, leading to the suggestion that they compose a hitherto hidden layer of genomic programming in humans and other complex organisms. However, to date, very few have been identified in genetic screens. Here I show that this is explicable by an historic emphasis, both phenotypically and technically, on mutations in protein-coding sequences, and by presumptions about the nature of regulatory mutations. Most variations in regulatory sequences produce relatively subtle phenotypic changes, in contrast to mutations in protein-coding sequences that frequently cause catastrophic component failure. Until recently, most mapping projects have focused on protein-coding sequences, and the limited number of identified regulatory mutations have been interpreted as affecting conventional cis-acting promoter and enhancer elements, although these regions are often themselves transcribed. Moreover, ncRNA-directed regulatory circuits underpin most, if not all, complex genetic phenomena in eukaryotes, including RNA interference-related processes such as transcriptional and post-transcriptional gene silencing, position effect variegation, hybrid dysgenesis, chromosome dosage compensation, parental imprinting and allelic exclusion, paramutation, and possibly transvection and transinduction. The next frontier is the identification and functional characterization of the myriad sequence variations that influence quantitative traits, disease susceptibility, and other complex characteristics, which are being shown by genome-wide association studies to lie mostly in noncoding, presumably regulatory, regions. There is every possibility that many of these variations will alter the interactions between regulatory RNAs and their targets, a prospect that should be borne in mind in future functional analyses
The long noncoding RNA Kcnq1ot1 organises a lineage-specific nuclear domain for epigenetic gene silencing
Long noncoding RNAs are implicated in a number of regulatory functions in
eukaryotic genomes. The paternally expressed long noncoding RNA (ncRNA)
Kcnq1ot1 regulates epigenetic gene silencing in an imprinted gene cluster in
cis over a distance of 400 kb in the mouse embryo, whereas the silenced region
extends over 780 kb in the placenta. Gene silencing by the Kcnq1ot1 RNA
involves repressive histone modifications, including H3K9me2 and H3K27me3,
which are partly brought about by the G9a and Ezh2 histone methyltransferases.
Here, we show that Kcnq1ot1 is transcribed by RNA polymerase II, is unspliced,
is relatively stable and is localised in the nucleus. Analysis of conditional
Dicer mutants reveals that the RNAi pathway is not involved in gene
silencing in the Kcnq1ot1 cluster. Instead, using RNA/DNA FISH we show that
the Kcnq1ot1 RNA establishes a nuclear domain within which the genes that are
epigenetically inactivated in cis are frequently found, whereas nearby genes
that are not regulated by Kcnq1ot1 are localised outside of the domain. The
Kcnq1ot1 RNA domain is larger in the placenta than in the embryo, consistent
with more genes in the cluster being silenced in the placenta. Our results
show for the first time that autosomal long ncRNAs can establish nuclear
domains, which might create a repressive environment for epigenetic silencing
of adjacent genes. Long ncRNAs in imprinting clusters and the Xist RNA on the
inactive X chromosome thus appear to regulate epigenetic gene silencing by
similar mechanisms